US Patent Issued to AGENUS, LUDWIG INSTITUTE FOR CANCER RESEARCH, MEMORIAL SLOAN-KETTERING CANCER CENTER on Dec. 9 for "Anti-CTLA-4 antibodies and methods of use thereof" (American, Dutch, German Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,257, issued on Dec. 9, was assigned to AGENUS INC. (Lexington, Mass.), LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (Zurich) and MEMORIAL SLOAN-KETTERING CANCER CENTER (New York).

"Anti-CTLA-4 antibodies and methods of use thereof" was invented by Marc Van Dijk (Bosch en Duin, Netherlands), Cornelia Anne Mundt (Lorrach, Germany), Gerd Ritter (New York), David Schaer (Mamaroneck, N.Y.), Jedd David Wolchok (New York), Taha Merghoub (Jersey City, N.J.), David Adam Savitsky (Boxford, Mass.) and Nicholas Stuart Wilson (San Carlos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The instant disclosure provides antibodies that specifically bind to human ...